ocrelizumab
roche
['multiple sclerosis', 'ensemble ', 'ocrelizumab', 'genentech']
new data from the phase 3b ensemble study assessing #ocrelizumab in patients with relapsing-remitting multiple sclerosis showed stable or improved disability progression in most patients treated up to 4 years. #aanam view: 
Delivering healthcare professionals treating neurological diseases quality and relevant information to help achieve the best patient care possible. #MindMoments